News

Transcranial Magnetic Stimulation (TMS) is a non-invasive stimulation procedure that uses transient electromagnetic fields to act in a focused manner on a particular brain region. It can be used as a therapy for depression, Parkinson's disease or...

Researchers from Inserm, CNRS, Sorbonne University and clinicians from the AP-HP and at Paris Brain Institute identified one of the mechanisms explaining ketamine effect as an antidepressant. Ketamine, usually used as an anesthetic, was administered...

The "Brain to Market" Summer School is an intensive 5-day training program to learn through practice the key skills of health entrepreneurship. Offered by the Open Brain School, the Paris Brain Institute's training organization, since 2015, this year...

A research team from the Paris Brain Institute (Inserm/CNRS/Sorbonne University/AP-HP) just identified mutations in familial cases with early-onset Parkinsonism and intellectual disability. Genetic studies on two affected siblings pairs highlighted...

The diagnosis of atypical forms of Alzheimer's disease is still sometimes difficult. Researchers from Paris Brain Institute have developed an automated algorithm to correlate the specificities of brain lesions with the symptoms associated with these...

It is with deep sadness that we inform you of the death of our colleague and friend, Prof. Charles Duyckaerts, who left us on the evening of Saturday, August 6, after several years of battling illness.

In a recent paper, published in Reviews of Modern Physics, Charley Presigny and Fabrizio de Vico Fallani (Inria) from the ARAMIS team from the Paris Brain Institute present a new mathematical model to decipher the brain organization and function in...

The International Brain Bee competition took place from July 4 to 9, in a remote format. In collaboration with the International Brain Bee Committee, the Institut du Cerveau participated in the organisation of this competition, the award ceremony for...

In 2021, the Institute’s teams were at the origin of important scientific breakthroughs, with the indispensable support of the technological platforms, whose restructuring has made it possible to meet everyone’s needs as well as possible.

Although Alzheimer's disease is not inherited in 95% of cases, nearly 75 genetic susceptibility factors - that is, factors that increase the risk to develop the disease - or protective factors - that decrease the probability to be affected - have...

The Institut du Cerveau – Paris Brain Institute is an internationally renowned neuroscience research institute located in Paris, France, on the campus of the Pitié-Salpêtrière hospital, providing world class expertise in basic and clinical...

The next forum organized by FENS (Federation of European Neuroscience Societies) will be held in Paris from 9 to 13 July 2022. The Paris Brain Institute’s researchers are mobilized for the largest ever symposium on neurosciences in Europe.